🇺🇸 FDA
Pipeline program

TAXOL 6 mg/ml, concentrato per soluzione per infusione

Phase 3 small_molecule active

Quick answer

TAXOL 6 mg/ml, concentrato per soluzione per infusione for Recurrent or Metastatic HER2 Negative Breast Cancer is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Recurrent or Metastatic HER2 Negative Breast Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials